ORIC Pharmaceuticals (ORIC) EV/EBIT: History & Chart

ORIC Pharmaceuticals, Inc.(ORIC)

Biotechnology · South San Francisco, CA

$11.80-0.69 (-5.54%)

Delayed quote: Oct 6, 2026, 3:35 PM EDT

About ORIC Pharmaceuticals, Inc.

ORIC Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to discovering and advancing innovative treatments for cancer patients across the United States. The company's pipeline includes several key clinical-stage drug candidates. ORIC-533 is an oral small molecule designed to inhibit CD73, addressing resistance to both chemotherapy and immunotherapy. Another candidate, ORIC-944, is an allosteric inhibitor targeting the polycomb repressive complex 2, specifically for the treatment of prostate cancer. Furthermore, ORIC-114 is a brain-penetrant, orally administered, irreversible inhibitor crafted to precisely target epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), demonstrating high potency against exon 20 insertion mutations. Beyond these advanced programs, ORIC Pharmaceuticals is also cultivating multiple early-stage precision medicines aimed at other mechanisms of cancer resistance. The company has established partnerships, including a licensing and collaboration agreement with Voronoi Inc., and a licensing agreement with Mirati Therapeutics, Inc. ORIC Pharmaceuticals was founded in 2014 and maintains its headquarters in South San Francisco, California.

South San Francisco, CA

111 employees

www.oricpharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Jacob Chacko

View full financials

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
ORIC Pharmaceuticals, Inc. (ORIC)	$1.22B	N/A	N/A	N/A	N/A
Cronos Group Inc. (CRON)vs ›	$1.22B	59.99x	63.01x	63.01x	63.01x
Omada Health (OMDA)vs ›	$1.23B	N/A	N/A	N/A	N/A
Innovage Holding Corp. (INNV)vs ›	$1.21B	18.98x	131.59x	131.59x	72.61x
Tyra Biosciences, Inc. (TYRA)vs ›	$1.20B	N/A	N/A	N/A	N/A
Kardigan, Inc. (KARD)vs ›	$1.22B	N/A	N/A	N/A	N/A
MannKind Corporation (MNKD)vs ›	$1.19B	189.92x	76.16x	60.11x	60.11x
Damora Therapeutics, Inc. (DMRA)vs ›	$1.17B	N/A	N/A	N/A	N/A
GoodRx Holdings, Inc. (GDRX)vs ›	$1.13B	17.10x	14.99x	31.51x	159.52x
Alpha Tau Medical Ltd (DRTS)vs ›	$1.31B	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EV/EBIT RATIO

TTM

ORIC Pharmaceuticals, Inc. (ORIC)

$1.22B

N/A

Cronos Group Inc. (CRON)vs ›

$1.22B

59.99x

63.01x

Omada Health (OMDA)vs ›